US Patent 7138229 Systems and methods for characterizing kidney diseases

Patent 7138229 was granted and assigned to RENOVAR, INC. on November, 2006 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 9 Oct, 2024

"update inverses"

Golden AI

edited on 9 Oct, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12110551 Combination of biomarkers for detecting and evaluating a hepatic fibrosis

Edits on 6 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 6 Sep, 2023

Edits made to:

Infobox (+2 properties)

Infobox

Patent Inventor Names

Huaizhong Hu0

Stuart Knechtle0

Edits on 31 Aug, 2023

"Add patent abstract"

Golden AI

edited on 31 Aug, 2023

Edits made to:

Article (+514 characters)

Article

Patent abstract

The present invention relates to methods of diagnosing, predicting and monitoring kidney diseases, including acute renal failure, renal tubular interstitial disease and glomerulonephritis. In particular, the present invention relates to the detection, prediction and monitoring of kidney diseases by detection of CXCR3 and CCL chemokines in urine. The present invention further relates to methods and compositions for assessing the efficacy of agents and interventions used to treat kidney diseases.

Edits on 24 May, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 24 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=071382290

Edits on 20 May, 2023

"Remove leading 0 from patent number"

Golden AI